Dosage and administration
One tablet daily or as directed by a physician.
OB Complete Premier
- Manufacturer
- Vertical Pharmaceuticals, LLC
- Effective date
- 2022-02-18
- Label type
- DIETARY SUPPLEMENT
- Version
- 10
- Source
- full-release
- Hydrated at
- 2026-06-01 02:50:22
Label at a glance#
ProductOB Complete Premier
Active ingredientBETA CAROTENE, CALCIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM MALATE, IRON PENTACARBONYL, FERROUS ASPARTO GLYCINATE, MAGNESIUM MALATE, ZINC GLYCINATE, CUPRIC GLYCINATE
Label structure12 sections
Contacts and useful links#
Websitewww.fda.gov
www.fda.gov/medwatch
www.fda.gov/medwatchLabel contents#
Full prescribing information#
SUPPLEMENT FACTS
Other Ingredients: Microcrystalline Cellulose, DiCal Phosphate, Croscarmellose Sodium, Pink Color Coating (Hydroxypropylmethyl Cellulose, Polyvinyl Alcohol, Titanium Dioxide, Polyethylene Glycol, Talc and FDC Red #40 Lake), Fumed Silica, Stearic Acid, Magnesium Stearate, Acacia and Povidone K30.
VEGETARIAN FRIENDLY
GLUTEN-, LACTOSE- AND SUGAR-FREE
OB Complete® Premier is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.
CONTRAINDICATIONS
OB Complete® Premier should not be used by patients with a known hypersensitivity to any of the listed ingredients.
WARNINGS
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
PRECAUTIONS
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
DRUG INTERACTIONS
OB Complete® Premier tablets are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
ADVERSE REACTIONS
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
DESCRIPTION
OB Complete® Premier is pink tablet, imprinted "VP043".
DIRECTIONS FOR USE
One tablet daily or as directed by a physician.
HOW SUPPLIED
OB Complete® Premier is supplied in a carton of 30 tablets, packaged in 3 child resistant unit-dose blister cards of 10 tablets per card.
Product Code: 68025-043-30
STORAGE
Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and excessive heat.
HEALTH CLAIM SECTION
KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.
*DimaCal and TRAACS are registered trademarks of Albion International, Inc. Malates covered by U.S. Patent No. 6,706,904. Chelate covered by U.S. Patent No. 7,838,042 and patents pending.
**Sumalate® (Ferrous Asparto Glycinate) is a registered trademark of Albion International, Inc. and is covered by the following patents: U.S. Pat. No. 6,716,814; U.S. Pat. No. 8,007,846 and U.S. Pat. No. 8,425,956.
For use on the order of a healthcare practitioner
Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-770-509-4500 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
PLR-OBCPR-00005-2 Rev. 02/2022
Distributed by:
Vertical Pharmaceuticals, LLC
Alpharetta, GA 30005
PRINCIPAL DISPLAY PANEL - 30 Tablet Blister Pack Carton
68025-043-30
Vegetarian Friendly,
Gluten, Lactose and
Sugar-Free
OB
COMPLETE®
Premier
30 Tablets
VERTICAL
PHARMACEUTICALS, LLC
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68025-043-30 | OB Complete Premier | 10 in 1 BLISTER PACK | TABLET, COATED | 10 | 10 | |
| 68025-043-30 | OB Complete Premier | 3 in 1 CARTON | TABLET, COATED | 3 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68025-043 | OB COMPLETE PREMIER (.BETA.-CAROTENE, CALCIUM ASCORBATE, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL SUCCINATE, D-, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, CALCIUM MALATE, IRON, FERROUS ASPARTO GLYCINATE, MAGNESIUM MALATE, ZINC GLYCINATE, AND COPPER) TABLET, COATED [VERTICAL PHARMACEUTICALS, LLC] | 10 | 2 package rows | 20220219_ccdc12f4-24f6-453f-a855-9ce4e91641f1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-043-30 | EA - Each | 68025-043 | 7adca518-4611-441e-b1d5-6adfa6353c26 | 1 | 2013-05-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Tocopherol Acetate, D- | ACTIVE INGREDIENT | A7E6112E4N | 3 | |
| .Beta.-Carotene | ACTIVE INGREDIENT | 01YAE03M7J | 3 | |
| Calcium Ascorbate | ACTIVE INGREDIENT | 183E4W213W | 3 | |
| Calcium Malate | ACTIVE INGREDIENT | D48OP746DW | 3 | |
| Cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 3 | |
| Cupric Glycinate | ACTIVE INGREDIENT | 68VAV8QID7 | 3 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 3 | |
| Ferrous Asparto Glycinate | ACTIVE INGREDIENT | H7426RGB3L | 3 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 3 | |
| Iron Pentacarbonyl | ACTIVE INGREDIENT | 6WQ62TAQ6Z | 3 | |
| Magnesium Malate | ACTIVE INGREDIENT | LA9X9UJA2Z | 3 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 3 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 3 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 3 | |
| Thiamine Mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 3 | |
| Zinc Glycinate | ACTIVE INGREDIENT | 681VJX72FE | 3 | |
| .Alpha.-Tocopherol, D- | ACTIVE MOIETY | N9PR3490H9 | 3 | |
| .Beta.-Carotene | ACTIVE MOIETY | 01YAE03M7J | 3 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 3 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | 3 | |
| Cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 3 | |
| Cupric Cation | ACTIVE MOIETY | 8CBV67279L | 3 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 3 | |
| Ferrous Cation | ACTIVE MOIETY | GW89581OWR | 3 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 3 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 3 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 3 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 3 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 3 | |
| Thiamine Ion | ACTIVE MOIETY | 4ABT0J945J | 3 | |
| Zinc Cation | ACTIVE MOIETY | 13S1S8SF37 | 3 | |
| Acacia | INACTIVE INGREDIENT | 5C5403N26O | 3 | |
| Calcium Phosphate | INACTIVE INGREDIENT | 97Z1WI3NDX | 3 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 3 | |
| Croscarmellose Sodium | INACTIVE INGREDIENT | M28OL1HH48 | 3 | |
| FD&C Red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | 3 | |
| Hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | 3 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 3 | |
| Polyethylene Glycols | INACTIVE INGREDIENT | 3WJQ0SDW1A | 3 | |
| Polyvinyl Alcohol | INACTIVE INGREDIENT | 532B59J990 | 3 | |
| Povidone K30 | INACTIVE INGREDIENT | U725QWY32X | 3 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 3 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 3 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 3 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 3 |
Products#
Every source-derived product name is available through these pages.
- OB Complete Premier
- .Beta.-Carotene, Calcium Ascorbate, Cholecalciferol, .Alpha.-Tocopherol Succinate, D-, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Calcium Malate, Iron, Ferrous Asparto Glycinate, Magnesium Malate, Zinc Glycinate, and Copper
- BETA CAROTENE
- CALCIUM ASCORBATE
- ASCORBIC ACID
- CHOLECALCIFEROL
- .ALPHA.-TOCOPHEROL SUCCINATE, D-
- .ALPHA.-TOCOPHEROL, D-
- THIAMINE MONONITRATE
- Thiamine ION
- THIAMINE
- RIBOFLAVIN
- NIACINAMIDE
- PYRIDOXINE HYDROCHLORIDE
- PYRIDOXINE
- FOLIC ACID
- CYANOCOBALAMIN
- CALCIUM MALATE
- CALCIUM CATION
- IRON PENTACARBONYL
- FERROUS CATION
- FERROUS ASPARTO GLYCINATE
- MAGNESIUM MALATE
- MAGNESIUM CATION
- ZINC GLYCINATE
- ZINC CATION
- CUPRIC GLYCINATE
- CUPRIC CATION
- CELLULOSE, MICROCRYSTALLINE
- CALCIUM PHOSPHATE
- CROSCARMELLOSE SODIUM
- HYPROMELLOSES
- POLYVINYL ALCOHOL, UNSPECIFIED
- TITANIUM DIOXIDE
- POLYETHYLENE GLYCOL, UNSPECIFIED
- TALC
- FD&C RED NO. 40
- SILICON DIOXIDE
- STEARIC ACID
- MAGNESIUM STEARATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68025-043 | 68025-043-30 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SHAMPOO / TOPICAL | 9.7 %w/w | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, DELAYED RELEASE / ORAL | 280 mg | ||
| Acacia | ACACIA | 5C5403N26O | POWDER, FOR SOLUTION / ORAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / ORAL | 420 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | 532B59J990 | SUSPENSION / ORAL | 5 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | INSERT / VAGINAL | 54.21 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOAP / TOPICAL | 6 %w/w | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | GUM, CHEWING / BUCCAL | 48 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE / ORAL | 72 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE / ORAL | 2169 mg | ||
| Povidone K30 | POVIDONE K30 | U725QWY32X | GRANULE / ORAL | 202 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED PELLETS / ORAL | NA | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SUSPENSION / ORAL | 100 mg/5ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / SUBLINGUAL | 10 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 336 mg | ||
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | 532B59J990 | TABLET, COATED / ORAL | 0.7 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | ELIXIR / ORAL | 12.5 mg/5ml | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | TABLET, COATED / ORAL | 58 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TAMPON / VAGINAL | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | RING / VAGINAL | 2 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | PASTE / DENTAL | 34 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE, DENTIFRICE / DENTAL | 0.4 %w/w | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE / ORAL | 16 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | TABLET, EXTENDED RELEASE / ORAL | 392 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, LIQUID FILLED / ORAL | 1 mg | ||
| Hypromelloses | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET / ORAL | 7 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET / ORAL | 232 mg | ||
| Talc | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / RESPIRATORY (INHALATION) | NA | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| FD&C Red No. 40 | FD&C RED NO. 40 | WZB9127XOA | SYRUP / ORAL | 3 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | EMULSION / TOPICAL | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / BUCCAL | 6 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, DELAYED RELEASE / ORAL | 40 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE / ORAL | 254 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE, EXTENDED RELEASE / ORAL | 64 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / ORAL | 6184 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | POWDER, FOR SUSPENSION / ORAL | 1203 mg/5ml | ||
| Croscarmellose Sodium | CROSCARMELLOSE SODIUM | M28OL1HH48 | SUSPENSION / ORAL | 150 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GRANULE, FOR SUSPENSION / ORAL | 143 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GEL / VAGINAL | 8 %w/w |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.